financetom
Business
financetom
/
Business
/
US CDC keeps COVID vaccine option for healthy children
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US CDC keeps COVID vaccine option for healthy children
May 30, 2025 7:50 PM

May 30 (Reuters) - The U.S. Centers for Disease Control

and Prevention said COVID-19 vaccines remain an option for

healthy children when parents and doctors agree that it is

needed, stopping short of Health Secretary Robert F. Kennedy

Jr.'s announcement that the agency would remove the shots from

its immunization schedule.

In a schedule published late on Thursday, the CDC said any

COVID vaccination in healthy children aged 6 months to 17 years

should follow "shared clinical decision-making" between a

child's parents and their healthcare provider.

It had previously recommended updated COVID vaccines for

everyone aged six months and older, following the guidance of

its panel of outside experts.

"Where the parent presents with a desire for their child to

be vaccinated, children 6 months and older may receive COVID-19

vaccination, informed by the clinical judgment of a healthcare

provider and personal preference and circumstances," the CDC

notice said. It provides instructions for administering the

shots to healthy children by age group, from infants to

teenagers.

Kennedy, a long-time vaccine skeptic who oversees the CDC,

the Food and Drug Administration and the National Institutes of

Health, had said on Tuesday the recommendations would be

dropped.

"As of today, the COVID vaccine for healthy children and

healthy pregnant women has been removed from the CDC recommended

immunization schedule," Kennedy said in a video posted on the X

platform.

A spokesperson for the Department of Health and Human

Services said there was no contradiction between Kennedy's

statement and the CDC schedule, which no longer provides a broad

recommendation for healthy children.

Kennedy's announcement prompted criticism from medical

experts who said the health secretary circumvented the

government's decision-making process on vaccines and could

prevent health insurance coverage for COVID shots to vulnerable

Americans.

The Infectious Diseases Society of America said on Tuesday

that removing the recommendation "does the opposite of what

Americans have been asking for when it comes to their health -

it takes away choices and will negatively impact them." It added

infants and children may "develop severe disease and may suffer

from prolonged symptoms due to long COVID, which can negatively

impact their development."

Nearly 1,900 children up to 18 years of age died of COVID in

the U.S., according to CDC estimates updated in 2023.

The makers of COVID vaccines available in the U.S. - Pfizer ( PFE )

, Moderna ( MRNA ) and Novavax ( NVAX ) - did not

immediately respond to requests for comment.

Traditionally, the CDC's Advisory Committee for Immunization

Practices would meet and vote on changes to the immunization

schedule or recommendations on who should get vaccines before

the agency's director made a final call. The committee had not

voted on the changes announced by Kennedy.

Last week, the FDA said it plans to require new clinical

trials for approval of annual COVID boosters for healthy

Americans under 65, effectively limiting them to older adults

and those at risk of developing severe illness.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Joseph Rallo's EF Hutton returns to Wall Street
Joseph Rallo's EF Hutton returns to Wall Street
Apr 9, 2025
(Reuters) - EF Hutton said on Wednesday it is making a comeback to Wall Street, reviving one of the most prominent brands in the brokerage industry. It will be led by CEO Joseph Rallo, who, along with former business partner David Boral, had previously resurrected the brand in 2021. Rallo and Boral positioned EF Hutton at the center of Wall...
US corporate bond market dries up on Trump tariff volatility
US corporate bond market dries up on Trump tariff volatility
Apr 9, 2025
* U.S. corporate bond market quiets on tariff war, Treasury market volatility * Bond spreads widen most in week after tariffs since first week of March 2023 regional bank stress * Five to six companies stay on sidelines after volatility, syndicate banker says (Updates with market commentary and Treasury auction results) By Matt Tracy April 9 (Reuters) - U.S. corporate...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
EXPLAINER-Prescription drugs become a target in Trump's trade war
EXPLAINER-Prescription drugs become a target in Trump's trade war
Apr 9, 2025
LONDON, April 9 (Reuters) - U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm to patients. Trump excluded them from his announcement of sweeping import tariffs last week, but in recent weeks he introduced tariffs on raw...
Copyright 2023-2026 - www.financetom.com All Rights Reserved